Institute of Experimental Diabetes Research, Hannover Medical School, Hannover, Germany.
Diabetes Metab Res Rev. 2017 Oct;33(7). doi: 10.1002/dmrr.2915. Epub 2017 Aug 2.
Animal models of human type 1 diabetes will be of a great importance for the evaluation of new combination therapies with curative potential. However, reliable predictive power for successful translation to patients with type 1 diabetes is crucial. This will be particularly important in the future when evaluating success of new combination therapies that show great promise for preservation and restoration of beta cell mass and thereby reverse the type 1 diabetic hyperglycaemia. But not all spontaneous animal models are equally well suited for this purpose. The advantages and disadvantages of the three spontaneous rat models (BioBreeding diabetes-prone [BB] rat, Komeda [KDP] rat, and LEW.1AR1-iddm [IDDM] rat) as well as the NOD mouse, compared with the characteristics of human type 1 diabetes, are considered in this review.
用于评估具有治愈潜力的新型联合疗法的人类 1 型糖尿病动物模型将具有重要意义。然而,对于成功转化为 1 型糖尿病患者的可靠预测能力至关重要。当评估显示出对β细胞质量的保护和恢复具有巨大潜力的新型联合疗法的成功时,这一点尤其重要,从而逆转 1 型糖尿病的高血糖。但并非所有自发性动物模型都同样适合这一目的。本文综述了三种自发性大鼠模型(BioBreeding 糖尿病易感[BB]大鼠、Komeda [KDP]大鼠和 LEW.1AR1-iddm [IDDM]大鼠)以及 NOD 小鼠与人类 1 型糖尿病特征的优缺点。